Inotuzumab, CAS [[1660159-36-3]]

Produktübersicht

• Artikelname: Inotuzumab, CAS [[1660159-36-3]]
• Artikelnummer: MCE-HY-P99264
• Hersteller Artikelnummer: HY-P99264
• Alternativnummer: MCE-HY-P99264-5MG,MCE-HY-P99264-10MG,MCE-HY-P99264-1MG,MCE-HY-P99264-25MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: Humanized Anti-CD22 Recombinant Antibody

Produktbeschreibung

Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4kappa antibody that targets human CD22. Inotuzumab can be linked to a toxic agent Ozogamicin as an antibody-drug conjugate (ADC), Inotuzumab ozogamicin (HY-P9959). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: (146.48 kDa)
• Reinheit: 96.81
• CAS Nummer: [1660159-36-3]
• Target-Kategorie: ADC Antibody,Apoptosis,CD22

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies